Notices. Notice; correction
191 words·~1 min read·
/register/2023/08/03/2023-16575A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4161-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2023-N-2850] Prescription Drug User Fee Rates for Fiscal Year 2024; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration is correcting a notice entitled “Prescription Drug User Fee Rates for Fiscal Year 2024” that appeared in the **Federal Register** of July 28, 2023. The document announced the rates for prescription drug user fees for fiscal year 2024.
The document was published with an incorrect value in a table. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, Legislation, and International Affairs, Food and Drug Administration, 301-796-9115, *Lisa.Granger@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: In the **Federal Register** of July 28, 2023 (88 FR 48881), in FR Doc. 2023-15911, the following correction is made: On page 48883, in section II.C., table 4, “CDER Actual FY 2022 Workload Volumes and Predicted FY 2024 Workload Volumes,” in the third column (“FY 2024 predictions”), fourth row (“NDA/BLA Original”), “1,136” is corrected to read “136.
” Dated: July 31, 2023. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2023-16575 Filed 8-2-23; 8:45 am]